Iris Pharma is one of the most respected global drug development services companies in ophthalmology

History

The origins of Iris Pharma date back to the late 1980’s when Dr Pierre-Paul Elena, a former research officer at Laboratoires Dulcis-Allergan (a French firm specializing in ophthalmic prescription drugs), identified a niche in the field of ocular drug development and recognized the pharmaceutical industry's growing need for pre-clinical outsourcing. This led Dr Elena to found Iris Pharma in 1989.

Iris Pharma is considered as a pioneer outsourcing services provider for ocular drug development and one of the first services companies to recognize the potential of this emerging market. Today this specialist CRO is one of the world leaders and most respected global drug development services companies in ophthalmology.

1989	Founding of Iris Pharma. Iris Pharma successfully provides its pre-clinical services through France and Europe.
1994	Iris Pharma tackles the American market and gains its first customers in the US.
1995	Iris Pharma becomes a GLP-certified laboratory.
2004	Launch of the Research Department to develop new animal models and offer customized animal models to clients.
2006	Launch of the Pre-Clinical Formulation Department whose role is to develop and optimize ocular drug formulations for improved delivery.
2007	Merger with Clirophtha, a unique Contract Research Organization in Europe and North America who were established in 1994 and were dedicated to clinical trials in ophthalmology. Since 2002, Clirophtha has also been an independent expert for the European Vision Institute. Clinical Trials. Sites of Excellence (EVI.CT.SE), optimizing EVI’s network consolidation through consulting, site audits, and certification. This merger establishes a world n°1 CRO for global drug development in ophthalmology.
2008	New Paris (France) premises at the "Institut de la Vision", one of Europe's major research center dedicated to eye diseases. Expansion of animal housing facilities in La Gaude (France). Partnership with the "Institut de la Vision". Iris Pharma becomes one of the main partners of this international research center for eye diseases.

Download

Fact sheet

» Back to the top